APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gout Medications

Compare research editions
View pricing & licenses

Selected research

Industry Research

Gout Medications Industry Research Report 2026

28 December 2025132 pages

Choose your research edition.

Industry ResearchGout Medications Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Gout Medications Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Gout Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gout Medications Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Gout Medications Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Gout Medications market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Gout Medications is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Gout Medications is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Gout Medications is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Gout Medications include AstraZeneca, FUJI YAKUHIN, Hikma Pharmaceuticals plc, lroko Pharmaceuticals, Merck, Novartis, Sanofi, Savient Pharmaceuticals, Inc. and Sebelalreland, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Gout Medications market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Gout Medications Market by Company

AstraZeneca

FUJI YAKUHIN

Hikma Pharmaceuticals plc

lroko Pharmaceuticals

Merck

Novartis

Sanofi

Savient Pharmaceuticals, Inc.

Sebelalreland

Takeda Pharmaceutical Company Limited

Teijin Pharma

Astellas Pharma Hong Kong Co., Ltd

Haichuang Pharmaceutical

Hengrui Medicine

Tonghua Dongbao

ApicHope

INVENTISBIO CO. LTD.

Gout Medications Segment by Type

Gout Relief Drugs

Gout Treatment Drugs

Gout Medications Segment by Application

Primary Gout

Secondary Gout

Gout Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gout Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gout Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gout Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Gout Medications manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Gout Medications by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Gout Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Gout Medications Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Gout Medications Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Gout Medications Sales Market Share by Manufacturers (2021-2026) Table 8. Global Gout Medications Revenue of Manufacturers (2021-2026) Table 9. Global Gout Medications Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Gout Medications Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Gout Medications Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Gout Medications, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Gout Medications, Product Type & Application Table 14. Global Gout Medications Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Gout Medications by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. AstraZeneca Company Information Table 19. AstraZeneca Business Overview Table 20. AstraZeneca Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. AstraZeneca Gout Medications Product Portfolio Table 22. AstraZeneca Recent Developments Table 23. FUJI YAKUHIN Company Information Table 24. FUJI YAKUHIN Business Overview Table 25. FUJI YAKUHIN Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. FUJI YAKUHIN Gout Medications Product Portfolio Table 27. FUJI YAKUHIN Recent Developments Table 28. Hikma Pharmaceuticals plc Company Information Table 29. Hikma Pharmaceuticals plc Business Overview Table 30. Hikma Pharmaceuticals plc Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Hikma Pharmaceuticals plc Gout Medications Product Portfolio Table 32. Hikma Pharmaceuticals plc Recent Developments Table 33. lroko Pharmaceuticals Company Information Table 34. lroko Pharmaceuticals Business Overview Table 35. lroko Pharmaceuticals Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. lroko Pharmaceuticals Gout Medications Product Portfolio Table 37. lroko Pharmaceuticals Recent Developments Table 38. Merck Company Information Table 39. Merck Business Overview Table 40. Merck Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Merck Gout Medications Product Portfolio Table 42. Merck Recent Developments Table 43. Novartis Company Information Table 44. Novartis Business Overview Table 45. Novartis Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Novartis Gout Medications Product Portfolio Table 47. Novartis Recent Developments Table 48. Sanofi Company Information Table 49. Sanofi Business Overview Table 50. Sanofi Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Sanofi Gout Medications Product Portfolio Table 52. Sanofi Recent Developments Table 53. Savient Pharmaceuticals, Inc. Company Information Table 54. Savient Pharmaceuticals, Inc. Business Overview Table 55. Savient Pharmaceuticals, Inc. Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Savient Pharmaceuticals, Inc. Gout Medications Product Portfolio Table 57. Savient Pharmaceuticals, Inc. Recent Developments Table 58. Sebelalreland Company Information Table 59. Sebelalreland Business Overview Table 60. Sebelalreland Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Sebelalreland Gout Medications Product Portfolio Table 62. Sebelalreland Recent Developments Table 63. Takeda Pharmaceutical Company Limited Company Information Table 64. Takeda Pharmaceutical Company Limited Business Overview Table 65. Takeda Pharmaceutical Company Limited Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Takeda Pharmaceutical Company Limited Gout Medications Product Portfolio Table 67. Takeda Pharmaceutical Company Limited Recent Developments Table 68. Teijin Pharma Company Information Table 69. Teijin Pharma Business Overview Table 70. Teijin Pharma Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Teijin Pharma Gout Medications Product Portfolio Table 72. Teijin Pharma Recent Developments Table 73. Astellas Pharma Hong Kong Co., Ltd Company Information Table 74. Astellas Pharma Hong Kong Co., Ltd Business Overview Table 75. Astellas Pharma Hong Kong Co., Ltd Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Astellas Pharma Hong Kong Co., Ltd Gout Medications Product Portfolio Table 77. Astellas Pharma Hong Kong Co., Ltd Recent Developments Table 78. Haichuang Pharmaceutical Company Information Table 79. Haichuang Pharmaceutical Business Overview Table 80. Haichuang Pharmaceutical Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Haichuang Pharmaceutical Gout Medications Product Portfolio Table 82. Haichuang Pharmaceutical Recent Developments Table 83. Hengrui Medicine Company Information Table 84. Hengrui Medicine Business Overview Table 85. Hengrui Medicine Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Hengrui Medicine Gout Medications Product Portfolio Table 87. Hengrui Medicine Recent Developments Table 88. Tonghua Dongbao Company Information Table 89. Tonghua Dongbao Business Overview Table 90. Tonghua Dongbao Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Tonghua Dongbao Gout Medications Product Portfolio Table 92. Tonghua Dongbao Recent Developments Table 93. ApicHope Company Information Table 94. ApicHope Business Overview Table 95. ApicHope Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. ApicHope Gout Medications Product Portfolio Table 97. ApicHope Recent Developments Table 98. INVENTISBIO CO. LTD. Company Information Table 99. INVENTISBIO CO. LTD. Business Overview Table 100. INVENTISBIO CO. LTD. Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. INVENTISBIO CO. LTD. Gout Medications Product Portfolio Table 102. INVENTISBIO CO. LTD. Recent Developments Table 103. Global Gout Medications Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Gout Medications Sales by Region (2021-2026) & (K Units) Table 105. Global Gout Medications Sales Market Share by Region (2021-2026) Table 106. Global Gout Medications Sales by Region (2027-2032) & (K Units) Table 107. Global Gout Medications Sales Market Share by Region (2027-2032) Table 108. Global Gout Medications Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Gout Medications Revenue Market Share by Region (2021-2026) Table 110. Global Gout Medications Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Gout Medications Revenue Market Share by Region (2027-2032) Table 112. North America Gout Medications Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Gout Medications Sales by Country (2021-2026) & (K Units) Table 114. North America Gout Medications Sales by Country (2027-2032) & (K Units) Table 115. North America Gout Medications Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Gout Medications Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Gout Medications Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Gout Medications Sales by Country (2021-2026) & (K Units) Table 119. Europe Gout Medications Sales by Country (2027-2032) & (K Units) Table 120. Europe Gout Medications Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Gout Medications Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Gout Medications Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Gout Medications Sales by Country (2021-2026) & (K Units) Table 124. Asia Pacific Gout Medications Sales by Country (2027-2032) & (K Units) Table 125. Asia Pacific Gout Medications Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Gout Medications Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Gout Medications Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Gout Medications Sales by Country (2021-2026) & (K Units) Table 129. South America Gout Medications Sales by Country (2027-2032) & (K Units) Table 130. South America Gout Medications Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Gout Medications Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Gout Medications Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Gout Medications Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Gout Medications Sales by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Gout Medications Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Gout Medications Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Gout Medications Sales by Type (2021-2026) & (K Units) Table 138. Global Gout Medications Sales by Type (2027-2032) & (K Units) Table 139. Global Gout Medications Sales Market Share by Type (2021-2026) Table 140. Global Gout Medications Sales Market Share by Type (2027-2032) Table 141. Global Gout Medications Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Gout Medications Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Gout Medications Revenue Market Share by Type (2021-2026) Table 144. Global Gout Medications Revenue Market Share by Type (2027-2032) Table 145. Global Gout Medications Price by Type (2021-2026) & (US$/Unit) Table 146. Global Gout Medications Price by Type (2027-2032) & (US$/Unit) Table 147. Global Gout Medications Sales by Application (2021-2026) & (K Units) Table 148. Global Gout Medications Sales by Application (2027-2032) & (K Units) Table 149. Global Gout Medications Sales Market Share by Application (2021-2026) Table 150. Global Gout Medications Sales Market Share by Application (2027-2032) Table 151. Global Gout Medications Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Gout Medications Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Gout Medications Revenue Market Share by Application (2021-2026) Table 154. Global Gout Medications Revenue Market Share by Application (2027-2032) Table 155. Global Gout Medications Price by Application (2021-2026) & (US$/Unit) Table 156. Global Gout Medications Price by Application (2027-2032) & (US$/Unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Gout Medications Distributors List Table 160. Gout Medications Customers List Table 161. Gout Medications Industry Trends Table 162. Gout Medications Industry Drivers Table 163. Gout Medications Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Gout Medications Product Image Figure 5. Global Gout Medications Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Gout Medications Market Size (2021-2032) & (US$ Million) Figure 7. Global Gout Medications Sales (2021-2032) & (K Units) Figure 8. Global Gout Medications Average Price (US$/Unit) & (2021-2032) Figure 9. Gout Relief Drugs Product Image Figure 10. Gout Treatment Drugs Product Image Figure 11. Primary Gout Product Image Figure 12. Secondary Gout Product Image Figure 13. Global Gout Medications Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Gout Medications, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Gout Medications Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Gout Medications Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Gout Medications Sales by Region in 2025 Figure 19. Global Gout Medications Revenue by Region in 2025 Figure 20. North America Gout Medications Market Size by Country in 2025 Figure 21. North America Gout Medications Sales Market Share by Country (2021-2032) Figure 22. North America Gout Medications Revenue Market Share by Country (2021-2032) Figure 23. United States Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Gout Medications Market Size by Country in 2025 Figure 27. Europe Gout Medications Sales Market Share by Country (2021-2032) Figure 28. Europe Gout Medications Revenue Market Share by Country (2021-2032) Figure 29. Germany Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Gout Medications Market Size by Country in 2025 Figure 40. Asia Pacific Gout Medications Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Gout Medications Revenue Market Share by Country (2021-2032) Figure 42. China Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Gout Medications Market Size by Country in 2025 Figure 51. South America Gout Medications Sales Market Share by Country (2021-2032) Figure 52. South America Gout Medications Revenue Market Share by Country (2021-2032) Figure 53. Brazil Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Gout Medications Market Size by Country in 2025 Figure 57. Middle East and Africa Gout Medications Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Gout Medications Revenue Market Share by Country (2021-2032) Figure 59. Egypt Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Gout Medications Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Gout Medications Sales Market Share by Type (2021-2032) Figure 65. Global Gout Medications Revenue Market Share by Type (2021-2032) Figure 66. Global Gout Medications Price (US$/Unit) by Type (2021-2032) Figure 67. Global Gout Medications Sales Market Share by Application (2021-2032) Figure 68. Global Gout Medications Revenue Market Share by Application (2021-2032) Figure 69. Global Gout Medications Price (US$/Unit) by Application (2021-2032) Figure 70. Gout Medications Value Chain Figure 71. Gout Medications Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Gout Medications Industry Opportunities and Challenges

Scope & coverage.

Types
  • Gout Relief Drugs
  • Gout Treatment Drugs
Applications
  • Primary Gout
  • Secondary Gout
Companies covered
  • AstraZeneca
  • FUJI YAKUHIN
  • Hikma Pharmaceuticals plc
  • lroko Pharmaceuticals
  • Merck
  • Novartis
  • Sanofi
  • Savient Pharmaceuticals, Inc.
  • Sebelalreland
  • Takeda Pharmaceutical Company Limited
  • Teijin Pharma
  • Astellas Pharma Hong Kong Co., Ltd
  • Haichuang Pharmaceutical
  • Hengrui Medicine
  • Tonghua Dongbao
  • ApicHope
  • INVENTISBIO CO. LTD.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Gout Medications Market Size (2021-2032)
  4. 2.2.2 Global Gout Medications Sales (2021-2032)
  5. 2.2.3 Global Gout Medications Market Average Price (2021-2032)
  6. 2.3 Gout Medications by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Gout Relief Drugs
  9. 2.3.3 Gout Treatment Drugs
  10. 2.4 Gout Medications by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Primary Gout
  13. 2.4.3 Secondary Gout
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Gout Medications Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Gout Medications Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Gout Medications Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Gout Medications Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Gout Medications Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Gout Medications, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Gout Medications, Product Type & Application
  8. 3.8 Global Manufacturers of Gout Medications, Established Date
  9. 3.9 Global Gout Medications Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 AstraZeneca
  2. 4.1.1 AstraZeneca Company Information
  3. 4.1.2 AstraZeneca Business Overview
  4. 4.1.3 AstraZeneca Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 AstraZeneca Gout Medications Product Portfolio
  6. 4.1.5 AstraZeneca Recent Developments
  7. 4.2 FUJI YAKUHIN
  8. 4.2.1 FUJI YAKUHIN Company Information
  9. 4.2.2 FUJI YAKUHIN Business Overview
  10. 4.2.3 FUJI YAKUHIN Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 FUJI YAKUHIN Gout Medications Product Portfolio
  12. 4.2.5 FUJI YAKUHIN Recent Developments
  13. 4.3 Hikma Pharmaceuticals plc
  14. 4.3.1 Hikma Pharmaceuticals plc Company Information
  15. 4.3.2 Hikma Pharmaceuticals plc Business Overview
  16. 4.3.3 Hikma Pharmaceuticals plc Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Hikma Pharmaceuticals plc Gout Medications Product Portfolio
  18. 4.3.5 Hikma Pharmaceuticals plc Recent Developments
  19. 4.4 lroko Pharmaceuticals
  20. 4.4.1 lroko Pharmaceuticals Company Information
  21. 4.4.2 lroko Pharmaceuticals Business Overview
  22. 4.4.3 lroko Pharmaceuticals Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 lroko Pharmaceuticals Gout Medications Product Portfolio
  24. 4.4.5 lroko Pharmaceuticals Recent Developments
  25. 4.5 Merck
  26. 4.5.1 Merck Company Information
  27. 4.5.2 Merck Business Overview
  28. 4.5.3 Merck Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Merck Gout Medications Product Portfolio
  30. 4.5.5 Merck Recent Developments
  31. 4.6 Novartis
  32. 4.6.1 Novartis Company Information
  33. 4.6.2 Novartis Business Overview
  34. 4.6.3 Novartis Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Novartis Gout Medications Product Portfolio
  36. 4.6.5 Novartis Recent Developments
  37. 4.7 Sanofi
  38. 4.7.1 Sanofi Company Information
  39. 4.7.2 Sanofi Business Overview
  40. 4.7.3 Sanofi Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Sanofi Gout Medications Product Portfolio
  42. 4.7.5 Sanofi Recent Developments
  43. 4.8 Savient Pharmaceuticals, Inc.
  44. 4.8.1 Savient Pharmaceuticals, Inc. Company Information
  45. 4.8.2 Savient Pharmaceuticals, Inc. Business Overview
  46. 4.8.3 Savient Pharmaceuticals, Inc. Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Savient Pharmaceuticals, Inc. Gout Medications Product Portfolio
  48. 4.8.5 Savient Pharmaceuticals, Inc. Recent Developments
  49. 4.9 Sebelalreland
  50. 4.9.1 Sebelalreland Company Information
  51. 4.9.2 Sebelalreland Business Overview
  52. 4.9.3 Sebelalreland Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Sebelalreland Gout Medications Product Portfolio
  54. 4.9.5 Sebelalreland Recent Developments
  55. 4.10 Takeda Pharmaceutical Company Limited
  56. 4.10.1 Takeda Pharmaceutical Company Limited Company Information
  57. 4.10.2 Takeda Pharmaceutical Company Limited Business Overview
  58. 4.10.3 Takeda Pharmaceutical Company Limited Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Takeda Pharmaceutical Company Limited Gout Medications Product Portfolio
  60. 4.10.5 Takeda Pharmaceutical Company Limited Recent Developments
  61. 4.11 Teijin Pharma
  62. 4.11.1 Teijin Pharma Company Information
  63. 4.11.2 Teijin Pharma Business Overview
  64. 4.11.3 Teijin Pharma Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Teijin Pharma Gout Medications Product Portfolio
  66. 4.11.5 Teijin Pharma Recent Developments
  67. 4.12 Astellas Pharma Hong Kong Co., Ltd
  68. 4.12.1 Astellas Pharma Hong Kong Co., Ltd Company Information
  69. 4.12.2 Astellas Pharma Hong Kong Co., Ltd Business Overview
  70. 4.12.3 Astellas Pharma Hong Kong Co., Ltd Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Astellas Pharma Hong Kong Co., Ltd Gout Medications Product Portfolio
  72. 4.12.5 Astellas Pharma Hong Kong Co., Ltd Recent Developments
  73. 4.13 Haichuang Pharmaceutical
  74. 4.13.1 Haichuang Pharmaceutical Company Information
  75. 4.13.2 Haichuang Pharmaceutical Business Overview
  76. 4.13.3 Haichuang Pharmaceutical Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Haichuang Pharmaceutical Gout Medications Product Portfolio
  78. 4.13.5 Haichuang Pharmaceutical Recent Developments
  79. 4.14 Hengrui Medicine
  80. 4.14.1 Hengrui Medicine Company Information
  81. 4.14.2 Hengrui Medicine Business Overview
  82. 4.14.3 Hengrui Medicine Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Hengrui Medicine Gout Medications Product Portfolio
  84. 4.14.5 Hengrui Medicine Recent Developments
  85. 4.15 Tonghua Dongbao
  86. 4.15.1 Tonghua Dongbao Company Information
  87. 4.15.2 Tonghua Dongbao Business Overview
  88. 4.15.3 Tonghua Dongbao Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Tonghua Dongbao Gout Medications Product Portfolio
  90. 4.15.5 Tonghua Dongbao Recent Developments
  91. 4.16 ApicHope
  92. 4.16.1 ApicHope Company Information
  93. 4.16.2 ApicHope Business Overview
  94. 4.16.3 ApicHope Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 ApicHope Gout Medications Product Portfolio
  96. 4.16.5 ApicHope Recent Developments
  97. 4.17 INVENTISBIO CO. LTD.
  98. 4.17.1 INVENTISBIO CO. LTD. Company Information
  99. 4.17.2 INVENTISBIO CO. LTD. Business Overview
  100. 4.17.3 INVENTISBIO CO. LTD. Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 INVENTISBIO CO. LTD. Gout Medications Product Portfolio
  102. 4.17.5 INVENTISBIO CO. LTD. Recent Developments
5 Global Gout Medications Market Scenario by Region
  1. 5.1 Global Gout Medications Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Gout Medications Sales by Region: 2021-2032
  3. 5.2.1 Global Gout Medications Sales by Region: 2021-2026
  4. 5.2.2 Global Gout Medications Sales by Region: 2027-2032
  5. 5.3 Global Gout Medications Revenue by Region: 2021-2032
  6. 5.3.1 Global Gout Medications Revenue by Region: 2021-2026
  7. 5.3.2 Global Gout Medications Revenue by Region: 2027-2032
  8. 5.4 North America Gout Medications Market Facts & Figures by Country
  9. 5.4.1 North America Gout Medications Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Gout Medications Sales by Country (2021-2032)
  11. 5.4.3 North America Gout Medications Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Gout Medications Market Facts & Figures by Country
  16. 5.5.1 Europe Gout Medications Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Gout Medications Sales by Country (2021-2032)
  18. 5.5.3 Europe Gout Medications Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Gout Medications Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Gout Medications Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Gout Medications Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Gout Medications Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Gout Medications Market Facts & Figures by Country
  41. 5.7.1 South America Gout Medications Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Gout Medications Sales by Country (2021-2032)
  43. 5.7.3 South America Gout Medications Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Gout Medications Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Gout Medications Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Gout Medications Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Gout Medications Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Gout Medications Sales by Type (2021-2032)
  2. 6.1.1 Global Gout Medications Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Gout Medications Sales Market Share by Type (2021-2032)
  4. 6.2 Global Gout Medications Revenue by Type (2021-2032)
  5. 6.2.1 Global Gout Medications Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Gout Medications Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Gout Medications Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Gout Medications Sales by Application (2021-2032)
  2. 7.1.1 Global Gout Medications Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Gout Medications Sales Market Share by Application (2021-2032)
  4. 7.2 Global Gout Medications Revenue by Application (2021-2032)
  5. 7.2.1 Global Gout Medications Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Gout Medications Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Gout Medications Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Gout Medications Value Chain Analysis
  2. 8.1.1 Gout Medications Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Gout Medications Production Mode & Process
  5. 8.2 Gout Medications Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Gout Medications Distributors
  8. 8.2.3 Gout Medications Customers
9 Global Gout Medications Analyzing Market Dynamics
  1. 9.1 Gout Medications Industry Trends
  2. 9.2 Gout Medications Industry Drivers
  3. 9.3 Gout Medications Industry Opportunities and Challenges
  4. 9.4 Gout Medications Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst